Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Amber Kanwar's 'deep' dive into CXR pricing
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Marcel7on May 06, 2016 10:53am
180 Views
Post# 24847869

RE:Amber Kanwar's 'deep' dive into CXR pricing

RE:Amber Kanwar's 'deep' dive into CXR pricingWell there is this:

"In fact, since Concordia took ownership in October, the price of the pink eye drug, Fucithalmic, is actually unchanged. The price increased 50 per cent right before Concordia took ownership."

Marcel

cashflow98 wrote:
https://www.bnn.ca/News/2016/5/6/Concordia-Healthcare-Diving-deep-into-claims-of-sky-high-prices.aspx


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities